Mometasone Furoate Lotion
NDC Package 21922-072-01
Package Information
Mometasone Furoate lotions is a medication used to treat skin conditions such as eczema, psoriasis, allergies, and rash. This formulation utilizes a lotion delivery system. Marketed by Encube Ethicals, Inc., this product is identified by NDC 21922-072 and is authorized under FDA application ANDA076499.
Identification & Billing
- RxCUI: 151030 - mometasone furoate 0.1 % Topical Solution (Lotion)
- RxCUI: 151030 - mometasone furoate 1 MG/ML Topical Lotion
- RxCUI: 151030 - mometasone furoate 0.1 % Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 21922 - Encube Ethicals, Inc.
- 21922-072 - Mometasone Furoate
- 21922-072-01 - 1 BOTTLE in 1 BOTTLE / 60 mL in 1 BOTTLE
- 21922-072 - Mometasone Furoate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (21922-072). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 21922-072-01 identifies a specific commercial package of 1 bottle in 1 bottle / 60 ml in 1 bottle of Mometasone Furoate, a human prescription drug labeled by Encube Ethicals, Inc.. This lotion is formulated for topical use and contains mometasone furoate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Encube Ethicals, Inc. on January 22, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Mometasone decreases swelling (inflammation), itching, and redness. Mometasone is a medium-strength corticosteroid. This medication is available in several forms including cream, ointment, and lotion (solution). Your doctor will choose the type of product based on the skin condition/area of the body being treated.
How is this Encube Ethicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 21922007201. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.